Rini Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.66 Cr
- Paid Up Capital ₹ 1.14 M
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
- Satisfied Charges ₹ 8.68 M
- Revenue Growth 13.01%
- Profit Growth -9.60%
- Ebitda 2.63%
- Net Worth 20.83%
- Total Assets 17.00%
About Rini Life Science
Rini Life Science Private Limited (RLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 February 2004 and has a history of 20 years and 11 months. Its registered office is in Indore, Madhya Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.66 Cr and a paid-up capital of Rs 1.14 M.
The company currently has active open charges totaling ₹2.50 Cr. The company has closed loans amounting to ₹8.68 M, as per Ministry of Corporate Affairs (MCA) records.
Rajnish Chordia, Rakesh Chordia, and Gopal serve as directors at the Company.
Company Details
- LocationIndore, Madhya Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51101MP2004PTC016376
- Company No.
016376
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Rini Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajnish Chordia  | Whole-Time Director | 03-Feb-2004 | Current |
| Rakesh Chordia | Whole-Time Director | 03-Feb-2004 | Current |
| Gopal | Director | 30-Nov-2019 | Current |
Financial Performance of Rini Life Science.
Rini Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.01% increase. The company also saw a slight decrease in profitability, with a 9.6% decrease in profit. The company's net worth Soared by an impressive increase of 20.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rini Life Science?
Unlock access to Rini Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kriti Exim LlpRajnish Chordia and Rakesh Chordia are mutual person
- Ripride Remedies Private Limited
Rajnish Chordia is a mutual person
- Sanndesh Infra Builders Private Limited
Rajnish Chordia is a mutual person
Charges (Loans)
₹2.50 Cr
₹0.87 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2014 | Hdfc Bank Limited | ₹2.50 Cr | Open |
| 18 May 2017 | Hdfc Bank Limited | ₹1.18 M | Satisfied |
| 17 Feb 2007 | Indore Cloth Market Co Operative Bank Limited | ₹7.50 M | Satisfied |
How Many Employees Work at Rini Life Science?
Rini Life Science has a workforce of 59 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rini Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rini Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
